Patent · US Expired

Hybrid immunoglobulins

US5116964A · kind A · utility

799Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 22, 1989
Grant dateMay 26, 1992
Priority date
Expiry dateNov 22, 2009

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/705
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Immunoglobulin fusion polypeptides are provided, together with methods for making and using them, and nucleic acids encoding them. These polypeptides are useful as cell surface adhesion molecules and ligands, and are useful in therapeutic or diagnostic compositions and methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.